ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1668

Unmet Need in Early Rheumatoid Arthritis – Why Do Some Patients Do Badly Despite Modern Treat-to-target Strategies of Care? Results from the Scottish Early RA (SERA) Inception Cohort

Elizabeth Clarke1, Claire Wood1, Alistair Tindell1, Kay Graham1, Alasdair McIntosh2, Fraser Morton2 and Duncan Porter3, 1NHS Greater Glasgow and Clyde, Glasgow, United Kingdom, 2University of Glasgow, Glasgow, United Kingdom, 3University of Glasgow, Bearsden, United Kingdom

Meeting: ACR Convergence 2021

Keywords: psychosocial factors, quality of life, rheumatoid arthritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 9, 2021

Title: RA – Diagnosis, Manifestations, & Outcomes Poster IV: Outcomes, Trajectory of Disease, & Epidemiology (1645–1673)

Session Type: Poster Session D

Session Time: 8:30AM-10:30AM

Background/Purpose: ‘Treat to target’ strategies of care have significantly improved outcomes in people with early rheumatoid arthritis; nonetheless, a significant proportion of patients have impaired health related quality of life (HR-QOL). Identifying baseline predictors of poor HR-QOL could enable us to direct appropriate resources towards people at high risk for adverse outcomes.

Methods: The Scottish Early Rheumatoid Arthritis study (Dale et al, PMID:27829394) is an inception cohort of patients with newly diagnosed RA and undifferentiated arthritis recruited in Scotland between 2011 and 2015 and followed up prospectively. Data were collected on demographics (age, gender, body mass index [BMI], employment status), serology, mood (Hospital Anxiety and Depression Score [HAD]), disease activity (SDAI), disability (Health Assessment Questionnaire [HAQ]) and socioeconomic status (Scottish Index of Multiple Deprivation [SIMD]). HR-QOL was measured using EQ5D; index scores calculated using the UK EQ5D-3L time trade off value set (Dolan et al, PMID:9366889). Univariate and multivariate models were developed to identify baseline predictors of HR-QOL at 12 months.

Results: HR-QOL over time shows a non-parametric distribution (fig 1). Improvement was seen in all EQ5D dimensions (Mobility, Self-Care, Usual Activities, Pain/Discomfort, Anxiety/Depression) at 6 and 12 months compared to baseline (fig 2), with most improvement within 6 months. Those in the lowest quartile of HR-QOL at 12 months (EQ5D TTO 0.32 v 0.82, p< 0.001) had substantial unmet need compared to those in the other quartiles: persistent disease activity (SDAI 20.1 v 7.6, p< 0.001), disability (HAQ 1.6 v 0.5, p< 0.001), anxiety (49% v 11%, p< 0.001) and depression (41% v 4%, p< 0.001). Univariate prediction models showed that baseline social deprivation, unemployment, disability (HAQ >1), and presence of anxiety or depression were significantly associated with lower HR-QOL at 12 months; age, gender, BMI and baseline disease activity were not predictive. Patients in the lowest quartile of HR-QOL at 12 months were more likely to live in the most socially deprived areas (SIMD lowest quintile: 36% v 14%, p< 0.001; see table 1), had higher baseline disability (HAQ 1.53 v 1.02, p< 0.001), were more likely to have anxiety (HAD-anxiety >8: 49% v 21%, p< 0.001) and depression (HAD-depression >8: 42% v 12%, p< 0.001) compared to those in other quartiles. Multivariate prediction models identified social deprivation, employment status, anxiety and depression as statistically significant independent predictors of HR-QOL at 12 months.

Conclusion: Social deprivation, employment status, depression, and anxiety are independent predictors of poor HR-QOL outcomes in patients with newly diagnosed RA/inflammatory arthritis. Psychological ill-health and the impact of social deprivation are potentially modifiable. Research is needed into the efficacy of strategies (such as psychological support) that aim to mitigate the negative impact of these factors on HR-QOL. “Health inequalities and the social determinants of health are not a footnote to the determinants of health. They are the main issue.” (Prof M Marmot) – our data support this assertion in patients with RA.

Figure 1: Violin Plot of EQ5D Time Trade Off (TTO) changes over 24 months

Figure 2: EQ5D 3L at baseline, 6 months, and 12 months.

Table 1: Model of EQ5D Time Trade Off (TTO) at 12 Months with Scottish Index of Multiple Deprivation


Disclosures: E. Clarke, None; C. Wood, None; A. Tindell, None; K. Graham, None; A. McIntosh, None; F. Morton, None; D. Porter, Galvani, 5, Abbvie, 12, Sponsorship to attend scientific meetings.

To cite this abstract in AMA style:

Clarke E, Wood C, Tindell A, Graham K, McIntosh A, Morton F, Porter D. Unmet Need in Early Rheumatoid Arthritis – Why Do Some Patients Do Badly Despite Modern Treat-to-target Strategies of Care? Results from the Scottish Early RA (SERA) Inception Cohort [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/unmet-need-in-early-rheumatoid-arthritis-why-do-some-patients-do-badly-despite-modern-treat-to-target-strategies-of-care-results-from-the-scottish-early-ra-sera-inception-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/unmet-need-in-early-rheumatoid-arthritis-why-do-some-patients-do-badly-despite-modern-treat-to-target-strategies-of-care-results-from-the-scottish-early-ra-sera-inception-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology